Skip to content

Prospective Post Market Observational Pilot Study to Evaluate the Effectiveness of Burst Spinal Cord Stimulation in the Treatment of Discogenic Low Back Pain

Prospective Post Market Observational Pilot Study to Evaluate the Effectiveness of Burst Spinal Cord Stimulation in the Treatment of Discogenic Low Back Pain - Burst neurostimulation for chronic discogenic LBP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48334
Enrollment
20
Registered
2019-03-26
Start date
2019-05-16
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronische lage rugpijn vanuit de tussenwervelschijf chronic discogenic low back pain

Interventions

Burst spinal cord neurostimulation. If this type of stimulation proofs unsuccessful after a trial period, Dorsal root ganglion(DRG) stimulation of level L2 is optionally available for the patients a

Sponsors

Rijnstate Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Subject of either gender between 18 and 65 years of age 2. Subject is able and willing to comply with the follow-up schedule and protocol 3. Subject is able to provide written informed consent 4. Chronic low back pain of at least 6 months 5. History consistent with discogenic low back pain (e.g. Pain produced on lumbar motion, significant functional limitation in sitting duration and tolerance) 6. Neurolog1c exam without marked motor deficit 7 Definite/Highly Probable/Discogenic Pam as confirmed by provocative discography according to IASPllSI S guidelines* 8. Low Back Pain intensity should be 6 or higher measured on a NPRS at baseline 9 Meets all the inclusion criteria for the implantation of a neurostimulallon system as typically utilised in the study centre for patients with discogenic low back pain 10. Subject has been screened by a multi-disciplinary panel including a psychologist and deemed suitable for implantation

Exclusion criteria

Exclusion criteria: 1. Female subject of childbearing potential is pregnant/nursing or plans to become pregnant during the course of the study 2. Escalating or changing pain condition within the past month as evidenced by investigator examination 3. BMI 35 4. Subject has had injection therapy or radiofrequency treatment for their low back pain withinthe past 3 months 5.Subject currently has an active implantable device including ICD,pacemaker , spinal cord stimulator or intrathecal drug pump 6. Subject is unable to operate the device 7. Severe disc degeneration at the affected level as evidenced by >50% disc heightl on plain anteroposterior and lateral lumbar radiographs or CT/MRI. 8. Extruded or sequestered herniated nucleus pulposus at the affected level(s). 9. Previous lumbar back surgery (e.g. Laminectomy, discectomy or fusion) at the affected level(s) 10. Moderate to severe spinal stenosis due to osteophyte and/or ligamentous overgrowth as evidenced by MRI or CT in the previous 6 months 11. Moderate to severe endplate degenerative changes at the affected levels 12. Grade 1-2 spondylolisthesis 13. Previous Neurostimulation therapy

Design outcomes

Primary

MeasureTime frame
To determine the number (percentage) of subjects who achieve a sustained and clinically meaningful pain reduction compared to baseline(at least 30%) or 2 points on a numerical pain rating scale (NPRS) in the by burst stimulation treated subjects at 12 months follow-up.

Secondary

MeasureTime frame
* Subject Satisfaction with treatment will be assessed using the Pat ent GlobalImpression of Change (PGIC), a 7 point Likert scale * Number (percentage) of subjects who achieve a 250% reduction in the intensity of the LBP at 6 and 12 months FU * Pain relief (230% and

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)